stockrowKailera Therapeutics, Inc. (KLRA) vs Precigen, Inc. (PGEN)
- Kailera Therapeutics, Inc. KLRA 13.30 +0.68%
- Precigen, Inc. PGEN 4.54 −2.58%
Kailera Therapeutics, Inc. and Precigen, Inc. are both Biotechnology companies. Kailera Therapeutics, Inc. and Precigen, Inc. are of similar size ($1.7B and $1.7B). Kailera Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Precigen, Inc. trades at 61.8×. Precigen, Inc. has the higher net margin (15.6% vs 0.00%) and the higher return on invested capital (15.9% vs −182.9%). Across the 12 metrics below, Precigen, Inc. leads on 7 and Kailera Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | KLRA | PGEN | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 91.42% | 67.24% |
| Operating margin | 0.00% | 21.43% | 0.00% |
| Net margin | 0.00% | 15.55% | 0.00% |
| Free cash flow margin | 0.00% | (47.35%) | 0.00% |
| Return on equity | (85.74%) | 38.84% | (50.28%) |
| Return on assets | (55.25%) | 12.73% | (45.89%) |
| Return on invested capital | (182.92%) | 15.93% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack